Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Todd Neale

May 09, 2025

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

FDA to Add New Diversity Requirements for Certain Clinical Studies

Todd Neale

July 15, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Daily News

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

Yael L. Maxwell

March 07, 2024

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Daily News

The More Tweaks Made to PMA-Approved Devices, the More Likely a Recall

Caitlin E. Cox

April 13, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads

Todd Neale

January 19, 2023

News Conference News AHA 2022

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

L.A. McKeown

November 07, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Conference News ACC 2022

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

L.A. McKeown

April 03, 2022

News Daily News

Postmarketing Studies of CV Devices Still Lacking in the US

Caitlin E. Cox

March 17, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

Advertisement

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Little Pre- and Postmarket Testing for Most Recalled CV Devices

FDA to Add New Diversity Requirements for Certain Clinical Studies

Valvular Heart Disease Has a Diversity Problem

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

AHA Sums Up AI’s Potential in Cardiology, but Also the Hurdles Ahead

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Women and Minorities Underrepresented in Heart Valve Trials

The More Tweaks Made to PMA-Approved Devices, the More Likely a Recall

TCTMD’s Top 10 Most Popular Stories for February 2023

Only Half of Revascularized PAD Patients Receive GDMT

RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads

Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI

Good News and Bad for High-Intensity Statin Use in ASCVD

PROMPT-HF: Pop-up Alerts Improve HFrEF Medication Optimization

Postmarketing Studies of CV Devices Still Lacking in the US

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content